Insider Transactions in Q1 2023 at Voyager Therapeutics, Inc. (VYGR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2023
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
4,410
-4.14%
|
$30,870
$7.76 P/Share
|
|
Mar 20
2023
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,654
-4.77%
|
$25,578
$7.76 P/Share
|
|
Mar 20
2023
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,193
-3.25%
|
$15,351
$7.76 P/Share
|
|
Mar 15
2023
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,373
-16.73%
|
$122,984
$8.2 P/Share
|
|
Feb 23
2023
|
Neurocrine Biosciences Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,395,588
+33.89%
|
$35,164,704
$8.88 P/Share
|
|
Feb 17
2023
|
Peter P. Pfreundschuh Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,000
+18.91%
|
-
|
|
Feb 17
2023
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
738
-1.08%
|
$5,166
$7.45 P/Share
|
|
Feb 17
2023
|
Todd Alfred Carter Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+33.24%
|
-
|
|
Feb 17
2023
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,297
-3.0%
|
$23,079
$7.45 P/Share
|
|
Feb 17
2023
|
Alfred Sandrock President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+35.08%
|
-
|
|
Feb 17
2023
|
Robin Swartz Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+30.33%
|
-
|
|
Feb 13
2023
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
2,868
-2.54%
|
$20,076
$7.67 P/Share
|
|
Feb 13
2023
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
797
-2.27%
|
$5,579
$7.67 P/Share
|
|
Feb 02
2023
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,500,000
-32.02%
|
-
|
|
Feb 01
2023
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
128,642
-2.67%
|
$1,157,778
$9.32 P/Share
|
|
Jan 31
2023
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
185,000
-3.7%
|
$1,665,000
$9.25 P/Share
|
|
Jan 30
2023
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
75,000
-1.48%
|
$675,000
$9.03 P/Share
|
|
Jan 27
2023
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.98%
|
$450,000
$9.02 P/Share
|
|
Jan 25
2023
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.97%
|
$450,000
$9.22 P/Share
|
|
Jan 24
2023
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-1.9%
|
$900,000
$9.27 P/Share
|
|
Jan 23
2023
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
55,000
-1.03%
|
$495,000
$9.06 P/Share
|
|
Jan 20
2023
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-1.84%
|
$900,000
$9.15 P/Share
|
|
Jan 17
2023
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,106
-1.54%
|
$9,954
$9.96 P/Share
|
|
Jan 17
2023
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
2,188
-0.96%
|
$19,692
$9.96 P/Share
|
|
Jan 17
2023
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,188
-2.04%
|
$19,692
$9.96 P/Share
|
|
Jan 11
2023
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
110,000
-2.78%
|
$880,000
$8.5 P/Share
|
|
Jan 10
2023
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
336,400
-7.83%
|
$2,691,200
$8.05 P/Share
|
|
Jan 09
2023
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
456,000
-9.59%
|
$3,192,000
$7.67 P/Share
|
|
Jan 06
2023
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
388
-1.06%
|
$2,328
$6.41 P/Share
|